NDC 63323-175

NDC 63323-175

NDC 63323-175 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 63323-175
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 63323-175-30 [63323017530]

OXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA078810
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-09-17
Marketing End Date2010-07-16

Drug Details


© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.